Spirit Player Popped For Banned Substance 1-14-2011 - WNEM TV 5

Spirit Player Popped For Banned Substance 1-14-2011

The Canadian Hockey League and the Canadian Centre for Ethics in Sport announced Friday that two junior hockey players were each assessed an eight-game suspension for anti-doping rule violations.
The violations resulted from urine samples collected during in-competition doping control in November 2010 that revealed the presence of methylhexaneamine, a prohibited stimulant.
Under the rules of the CHL Anti-Doping Policy, Plymouth Whalers’ player Alexander Aleardi and Saginaw Spirit player Ryan O’Connor were each suspended eight games for a first violation for using a prohibited substance.
"This was a case where players inadvertently used an over the counter supplement that contained a banned substance in it," said Saginaw Spirit president and partner Craig Goslin, "In the case of Ryan O'Connor, we are disappointed for him that the use of an everyday product that can be purchased at any retail outlet or grocery store in this region would lead to an eight-game suspension and we feel that the number of games is exorbitant given what was taken and considering his impeccable character. However, we respect the guidelines established by the CHL and the CCES in its no-tolerance policy regarding methylhexaneamine."
“These players and the teams concerned were extremely cooperative throughout the process,” said CHL president and Ontario Hockey League commissioner David Branch. “We are completely satisfied that the players used a supplement which they had purchased over the counter at a local retail outlet and had no knowledge that it contained a stimulant.”
Methylhexaneamine is banned in-competition by the World Anti-Doping Agency’s Prohibited List, which is recognized by the CHL. In Canada, methylhexaneamine is not an ingredient in medications licensed by Health Canada but can be found in supplements.
Powered by Frankly
Powered by WorldNow CNN
All content © 2018, WNEM; Saginaw, MI. (A Meredith Corporation Station) . All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.